Structural Heart to Heart

Dr. Hemal Gada and Dr. Vijay Iyer dive into the debate over the efficacy of cerebral embolic protection in preventing TAVR-related stroke. Physicians in this episode were compensated for their participation.

Dr. Vinod Thourani speaks with Dr. James Kauten about the importance of reducing paravalvular leakage after transcatheter aortic valve replacement. Physicians in this episode were compensated for their participation.

In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era. Chapter 1: Treating TAVR Patients Today (0:46) Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27) Chapter 3: Patient and Procedural Strategy (14:55) Chapter 4: The Heart Team in a Virtual World (22:45) Chapter 5: The Impact on Clinical Trial Research (26:08)

Paravalvular leak leads to a less than optimal TAVR procedure. LOTUS Edge can virtually eliminate it. That’s what Dr. Vijay Iyer found, as he discusses this month with Dr. Hemal Gada on his experience with the LOTUS platform.

Today, TAVR might be viewed as a straightforward procedure. But from PVL to TAV-in-TAV, there’s still plenty of room for drama. This month, Dr. David Rizik and Dr. Saib Khogali sit down to discuss the ability of the LOTUS Edge Aortic Valve System to eliminate drama, delivering more successful procedures.

A new podcast by Boston Scientific where peers discuss timely topics in the structural heart field.